Gene Query: COTL1

Dataset Description Geneva Score
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma [RNA-seq] 97.5
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma 97.5
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 93.98
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 89.7
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 89.7
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 75.64
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 75.64
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 72.0
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 66.38
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 57.78
BCL11B 57.02
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 56.25
RNA-seq analyses of human prostate cancer cells 55.92
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 55.06
Nutritional control of protein translation 55.01
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 54.41
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 53.71
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 53.15
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 52.12
Small RNA-seq of human granulosa cells reveals miRNAs in FSHR and aromatase genes 51.34
High-throughput RNA sequencing of human preovulatory cumulus and mural granulosa cells (mRNA) 51.34
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 50.78
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 50.78
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 47.88
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 47.17
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 47.01
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 46.79
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 46.27
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 46.02
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 45.85
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 45.79
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 43.05
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 42.73
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 42.69
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 42.69
Gene expression analysis of immortalized human liver progenitor-like cells in culture 41.61
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 38.93
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 38.62
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 38.49
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 38.49
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 37.81
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 37.72
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 37.5
Dtx3L and Androgen Signaling in Prostate Cancer 37.38
RNA-seq data from human lymphoma cell lines 35.91
ChIP-seq and RNA-seq from human lymphoma cell lines 35.91
Transcriptomic analysis of human tonsillar TFH subsets 35.35
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 34.66
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 34.6
RNAseq of T-ALL upon long non coding rna purturbation 34.38
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 34.0
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 33.86
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 31.66
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 31.5
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 31.5
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 31.24
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 31.09
Transcriptome profiling of Normal and Cancerous Prostate Cells 31.04
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 30.61
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 30.61
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 30.19
RNA-sequencing of human peripheral blood mononuclear cells (PB MNCs) and induced neural progenitor cells derived from PB MNCs 29.76
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 29.73
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 29.73
RNA-seq in HepG2 and IMR90 cells 29.72
Evolution of a transcriptional regulator from a transmembrane nucleoporin 29.72
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 29.24
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 29.2
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 29.06
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 28.98
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 28.98
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 28.77
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 28.61
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 27.93
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 27.71
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 27.71
FOXD3 is a novel tumor suppressor in lung cancer 27.64
A prostate cancer chromatin interaction map 27.63
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 27.53
Gene expression profiling of human and murine in vitro muscle differentiation 27.19
RNA-Seq analysis of breast cancer cells after shikonin treatment 27.16
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 26.71
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 26.63
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 26.63
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 26.53
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 26.53
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 25.92
Unique features and clinical importance of acute alloreactive immune responses 25.91
Lipid degradation promotes prostate cancer cell survival 25.89
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 25.48
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 25.14
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 25.14
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 24.96
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 24.79
The role of FAM46C in myeloma cells 24.74
The role of FAM46C in myeloma cells [sequencing] 24.74
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 24.65
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 24.54
Genome wide expression change by RNF168 knocking down in NEC cells 24.45
Morphological and molecular characterization of human dermal lymphatic collectors 24.41
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 24.3
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 24.2
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 24.09
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 24.08
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 24.06
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 23.86
Depicting early human development and germ cell origin with porcine embryos 23.82
Differential Gene Expression between MCF10A and MCF7 cells 23.7
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 23.61
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 23.4
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 23.4
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 23.37
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 23.27
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 23.06
Genome wide miR-191 target profile determined by RIP and gene expression profiling 23.05
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 23.05
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 23.05
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 23.0
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 23.0
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 22.88
Differential gene expression profiles in imatinib-resistant cell lines 22.75
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 22.73
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 22.62
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier 22.61
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier [human] 22.61
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 22.12
Total RNA sequencing of APC mutant and wt colonic organoids 22.0
RNA-seq of stable and unstable section of human atherosclerotic plaques 21.98
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 21.57
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 21.45
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 21.06
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 20.96
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 20.78
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 20.7
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 20.7
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 20.6
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 20.6
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 20.58
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 20.58
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 20.51
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 20.35
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 20.34
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 20.26
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 19.91
Transcriptome analysis revealed impaired cAMP responsiveness in PHF21A-deficient human cells 19.88
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 19.7
Global gene expression profile of dasatinib-resistant RCH-ACV cells 19.57
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 19.46
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 19.4
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 19.4
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 19.37
RNA sequencing of hPSC-derived cardiac progenitors and endocardium 19.3
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 19.28
Human Treg NaCl stimulation 19.25
Differential expression of genes in AD169-infected MRC5. 19.05
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 18.98
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 18.98
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 18.89
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 18.89
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 18.85
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 18.85
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 18.84
IDH3a KO RNA-seq 18.83
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 18.81
A549 cells and MSR-A549 cells 18.81
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 18.57
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 18.56
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 18.48
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 18.44
ZIKV infection of monocytes activates inflammasome pathways 18.35
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 18.35
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 18.2
BAF controls genome accessibility 18.18
The landscape of alternative splicing in aggressive prostate cancers 18.1
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 18.09
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 18.05
Finding missing proteins from epigenetically manipulated human cells 18.04
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 18.04
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 17.95
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 17.95
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 17.95
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 17.88
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 17.81
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 17.81
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 17.77
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 17.7
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 17.56
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 17.49
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 17.49
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes 17.4
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes [RNA-seq] 17.4
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 17.28
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 17.27
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 17.25
Human neutrophil genome during PMA- and E. coli encounter-induced activation 17.25
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 17.15
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 17.02
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 17.0
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 16.99
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 16.97
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 16.8
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 16.8
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 16.73
Modeling Familial Cancer with iPSC Approaches 16.7
WRN knockout effects upon gene expression in SW48 and OVK18 16.7
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 16.51
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 16.44
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 16.4
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 16.39
Uridylation by TUT4 and TUT7 marks mRNA for degradation 16.37
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 16.2
NGS based identification of GD2-positive tumor-specific phenotype for cancer diagnostics and therapy 16.2
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 16.13
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 16.13
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 15.86
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 15.86
mRNA-Seq profiling of human developing kidney 15.83
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 15.73
RNA-seq analysis of breast cancer 15.6
RNA-seq analysis and shRNA screen of breast cancer 15.6
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 15.57
RNA seq_PDX2_SHP099 15.55
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 15.51
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 15.5
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 15.5
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 15.37
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 15.32
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 15.32
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 15.31
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] 15.29
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition 15.29
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 15.14
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 15.05
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 14.96
Transcriptome-wide identification of CELF2 functional targets in T cells 14.96
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 14.95
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 14.87
CD74 role in transcription regulation 14.86
CD74 role in transcription regulation [RNA-seq] 14.86
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 14.64
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 14.58
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 14.57
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance 14.54
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance (RNA-Seq) 14.54
Next Generation Sequencing of human SMA and healthy control Motor Neurons 14.47
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 14.46
Trans-differentiation of human adult peripheral blood T cells into neurons 14.41
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 14.35
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 14.23
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 14.19
JAK dependent survival of ALK- ALCL 14.16
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 14.13
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 14.11
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 14.08
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 14.08
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 14.05
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 14.01
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 14.0
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 13.98
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 13.98
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 13.96
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 13.91
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 13.87
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 13.83
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 13.68
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 13.68
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 13.61
MAIT cell RNA sequencing 13.57
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 13.56
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 13.51
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 13.38
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 13.38
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 13.38
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte [RNA-seq] 13.34
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte 13.34
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 13.33
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 13.33
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 13.31
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 13.31
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 13.3
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 13.3
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 13.21
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 13.03
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 12.98
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 12.94
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 12.94
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 12.91
AMPK signaling for naïve pluripotency 12.9
AMPK signaling for naïve pluripotency [Hs] 12.9
Role of microRNAs in the interaction between Salmonella and the host cell 12.9
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 12.78
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 12.71
Reconstruction of the Human Blood-Brain Barrier in vitro reveals a Pathogenic Mechanism of APOE4 in Pericytes 12.7
Gene expression profile in breast cancer cell lines using RNA sequencing 12.58
MiR-26 dampens IL-6 production by down-regulating TNF-a/NF-kB signaling through silencing HMGA1 and MALT1 and not by directly targeting IL-6 mRNA 12.57
PTP4A1 phosphatase is overexpressed in systemic sclerosis fibroblasts and promotes TGFb signaling 12.53
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 12.42
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 12.38
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 12.31
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 12.18
In situ CAPTURE of chromatin interactions by biotinylated dCas9 12.18
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 12.16
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 12.1
Characterization of human ILC2 subsets 12.08
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 12.05
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 11.89
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 11.72
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 11.65
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 11.63
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 11.63
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 11.63
Microprocessor mediates transcription termination in long noncoding microRNA genes 11.59
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 11.5
High-Throughput Kinetic Analysis of Fractional Killing 11.17
EWSR1 influences alternative splicing through direct and indirect mechanisms 11.1
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 10.94
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 10.92
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 10.89
ERBB3 and NGFR mark distinct skeletal muscle progenitor cells in human development enabling enrichment and maturation of hPSC muscle 10.84
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 10.67
Analysis of MGE Transcriptomes with or without Ctnnb1 knockout in human through RNA Sequencing 10.63
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 10.56
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 10.35
Endothelial gene expression analysis 10.35
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 10.21
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 10.07
Fusion discovery in breast cancer cell line 9.97
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 9.96
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 9.94
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 9.78
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 9.75
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 9.72
Zika virus directly infects human peripheral neurons and induces cell death 9.66
RNA-sequencing in irradiated and normal A549 cells. 9.65
Gene Expression Signature in Adipose Tissue of Acromegaly Patients 9.57
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 9.48
Loss of endometrial plasticity in recurrent pregnancy loss 9.48
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons 9.28
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 9.28
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 9.19
Widespread intronic polyadenylation diversifies immune cell transcriptomes 9.1
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 9.1
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 9.1
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 9.05
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 9.01
Exogenous rescue of KLHL9 in SF210 cell line 9.01
Gene expression profiling of KSHV-infected periodontal ligament cells 8.89
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 8.72
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 8.65
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 8.64
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 8.64
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 8.5
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 8.44
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 8.36
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 8.34
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 8.27
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 8.16
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 8.13
Generation and functional characterization of MDSC-like cells 8.09
Dynamic 3D chromosomal landscapes in acute leukemia 8.04
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 8.04
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 8.0
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 7.91
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 7.9
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo 7.79
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 7.7
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 7.45
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 7.29
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 7.26
RNA-sequencing of human tendon after injury 7.25
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 7.19
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 7.01
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 6.97
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 6.89
Reprogrammed myeloid cell transcriptomes in NSCLC 6.85
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 6.77
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 6.72
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 6.67
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 6.66
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 6.58
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 6.56
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization 6.55
Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells 6.55
Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells 6.55
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 6.54
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 6.4
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 6.39
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 6.31
The Genetic Landscape of Diamond-Blackfan Anemia 6.19
FOXP2's impact on the primate transcriptome 5.85
STX4 Over-Expression in Human islets 5.78
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 5.69
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 5.46
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 5.35
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 5.28
Oncogenic roles of ARID5B in T-ALL 5.28
Gene profiling of human adult and pediatric liver cancer cells 5.24
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 5.17
mRNA expression profile of Lymphocytes by high-throuput sequencing 5.09
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 5.06
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 5.01
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 4.93
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 4.92
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 4.91
hESC neural differentiation 4.81
RNA-seq analysis of gene expression patterns during hESC neural differentiation 4.81
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 4.78
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 4.78
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 4.62
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 4.57
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 4.23
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 4.11
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 4.1
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 4.1
Identification of long noncoding RNAs in T-ALL cell lines 4.06
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 4.03
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 4.02
Analyses of T-ALL (COG study) 4.0
RNA sequencing of T-ALL (COG study) 4.0
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 3.93
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels [RNA-Seq] 3.88
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels 3.88
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 3.86
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 3.84
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 3.83
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 3.8
RNA-seq of SCLC PDX models treated with EP 3.73
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 3.67
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 3.67
miR-93 Targets in Human Endothelial Cells 3.6
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 3.56
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 3.29
Identification of renal resident macrophages across species [C1] 3.18
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 3.18
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 3.09
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 3.07
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [RNA-Seq] 2.98
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [DNA Methylation] 2.98
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 2.97
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 2.9
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 2.9
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 2.89
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 2.64
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 2.63
The Cushing's disease adipose gene expression profile reveals effects of long term glucocorticoids on adipose tissue lipid, protein and glucose metabolism 2.61
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 2.54
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 2.48
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 2.46
Hepatic transcriptome of pediatric hepatoblastoma. 2.44
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 2.32
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 2.27
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 2.2
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 2.04
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 1.95
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 1.89
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 1.83
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 1.79
Anti-inflammatory effect of indoleacrylic acid (IA) 1.76
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 1.73
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 1.73
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 1.7
The pioneer factor CEBPA modulates vitamin D signaling 1.7
Clinker: visualizing fusion genes detected in RNA-seq data 1.7
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 1.67
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 1.53
Identifying deer antler proliferation and mineralization genes using comparative RNA-seq 1.51
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 1.48
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 1.45
Human Tfh cell RNA bulk sequencing 1.43
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 1.3
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 1.09
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 1.06
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 1.0
The role of the Calcium-Sensing receptor in colorectal cancer 0.98
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.92
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 0.9
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 0.9
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 0.84
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 0.81
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 0.8
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 0.64
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 0.57
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 0.48
Comparative Analysis of Cas9 Activators Across Multiple Species 0.46
Comparison of 7 small cell lung cancer PDX models, cultured ex vivo, for response to LSD1 inhibitor RG6016/ORY1001 0.4
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 0.33
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 0.33
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 0.3
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.3
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.27
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 0.26
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.22
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.22
mRNA sequencing of oropharyngeal cancer cell lines 0.17
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function 0.15
RNA sequencing analysis of selumetinib-resistant CRC cells lines 0.14
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 0.04
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 0.02
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.02
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation